Lee, B. Et Al. 2020. Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1. JOURNAL OF KNEE SURGERY , vol.33, no.2 , 167-172.

Lee, B., Parvizi, J., Bramlet, D., Romness, D. W., Guermazi, A., Noh, M., ... Sodhi, N.(2020). Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1. JOURNAL OF KNEE SURGERY , vol.33, no.2, 167-172.

Lee, Bumsup Et Al. "Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1," JOURNAL OF KNEE SURGERY , vol.33, no.2, 167-172, 2020

Lee, Bumsup Et Al. "Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1." JOURNAL OF KNEE SURGERY , vol.33, no.2, pp.167-172, 2020

Lee, B. Et Al. (2020) . "Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1." JOURNAL OF KNEE SURGERY , vol.33, no.2, pp.167-172.

@article{article, author={Bumsup Lee Et Al. }, title={Results of a Phase II Study to Determine the Efficacy and Safety of Genetically Engineered Allogeneic Human Chondrocytes Expressing TGF- β 1}, journal={JOURNAL OF KNEE SURGERY}, year=2020, pages={167-172} }